Deferoxamine Toxicity
Deferoxamine Toxicity is a clinical phenomenon characterized by adverse physiological effects arising from the accumulation or administration of deferoxamine, a siderophore-based chelating agent, distinguished from other drug-related toxicities by its specific association with iron chelation therapy and its impact on cellular metabolism, microbial susceptibility, and organ function.
95
Publications
4.8K
Citations
419
Authors
173
Institutions
Publications per year
2017–2026
12
Parents
95
Effects of a single course of deferoxamine in neuroblastoma patients.
Alberto Donfrancesco, G Deb, C Dominici et al. · PubMed · 1990 · 197 citations
Pharmacy, Oncology, Pharmacology +15
1–5 of 95
419
7
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 419
173
Hospital for Sick Children
Toronto, Canada
5 h-index
24 publications
5.6K citations
University College London
London, United Kingdom
4 h-index
12 publications
358 citations
University of Michigan
Ann Arbor, United States
4 h-index
8 publications
175 citations

University of Toronto
Toronto, Canada
4 h-index
14 publications
476 citations
West China Hospital of Sichuan University
Chengdu, China
3 h-index
16 publications
283 citations

Sichuan University
Chengdu, China
3 h-index
22 publications
463 citations
Washington Poison Center
Seattle, United States
3 h-index
6 publications
95 citations
AZ Sint-Jan
Bruges, Belgium
2 h-index
8 publications
2.6K citations
1–8 of 173
Repository · 16 publications · 765 citations
13
h-index
2 publications · 53 citations
2
h-index
2 publications · 49 citations
2
h-index
2 publications · 100 citations
2
h-index
TAAP · 2 publications · 112 citations
2
h-index
1–5